Product
L-ornithine L-aspartate
2 clinical trials
3 indications
Indication
CirrhosisIndication
Hepatic Encephalopathy Stage 2Indication
Hepatic EncephalopathyClinical trial
An Observational Study on the Effect of L-ornithine-L-aspertate (LOLA) on the Flavonifractor Abundance in the Gut Microbiome in Liver CirrhosisStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
HELP Trial: Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic EncephalopathyStatus: Not yet recruiting, Estimated PCD: 2024-04-01